239 filings
Page 9 of 12
424B3
jw1zq5rij806wi0hrg
25 Jul 17
Prospectus supplement
12:00am
8-K
owwrnuf8yj9xrsuc
11 Jul 17
Kadmon Announces Interim Phase 2 Data of KD025 in Chronic Graft-Versus-Host Disease
12:00am
424B3
fd22xb o1
11 Jul 17
Prospectus supplement
12:00am
8-K
rn9j1 3fb4162wkc6vpn
29 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
424B3
sv1w3aaby
29 Jun 17
Prospectus supplement
12:00am
8-K
8sv158tyn0mq8
23 Jun 17
Kadmon to Present Interim Data on KD025 in Chronic Graft-Versus-Host Disease (cGVHD) at R&D Day
12:00am
424B3
1mjsfsp5pr1e4lysr
23 Jun 17
Prospectus supplement
12:00am
8-K
t0e vvbrek0yc7ia
14 Jun 17
Departure of Directors or Certain Officers
12:00am
424B3
m3vn7on j0m1lpkcd
15 May 17
Prospectus supplement
12:00am
8-K
wex6a
15 May 17
Kadmon Provides Business Update and Reports First Quarter 2017 Financial Results
12:00am
DEF 14A
koi2u4g8
10 May 17
Definitive proxy
12:00am
424B3
49ira
21 Apr 17
Prospectus supplement
12:00am
EFFECT
oz77qc55c2 ck8
21 Apr 17
Notice of effectiveness
12:00am
CORRESP
14vffs77v0bev
19 Apr 17
Correspondence with SEC
12:00am
UPLOAD
mnj8qi4fh912t
18 Apr 17
Letter from SEC
12:00am
8-K
udpg1 xpkryr01
4 Apr 17
Other Events
12:00am
424B3
1o0wo7jwyeuy3peqa2
4 Apr 17
Prospectus supplement
12:00am
8-K
k8zba3pf6 2bzjmop
3 Apr 17
Kadmon Announces Amendment to Credit Agreement and Related Warrants
12:00am